References
Ryan, Kenneth, Ross Berkowitz, et al., eds. Kistner's Gynecology and Women's Health. 7th ed. St. Louis: Mosby, 1999. pp. 501-502.
"FDA Approves New Labels for Estrogen and Estrogen with Progestin Therapies for Postmenopausal Women Following Review of Women's Health Initiative Data." FDA News/Press Release. January 8, 2003. http://www.fda.gov. Accessed March 2003.
Grady D, Herrington D, Bittner V, et al, for the HERS Research Group. Heart and estrogen/progestin replacement study follow-up (HERS II): Part 1. Cardiovascular outcomes during 6.8 years of hormone therapy. JAMA 2002;288:49-57.
Hulley S, Furberg C, Barrett-Connor E, et al, for the HERS Research Group. Heart and estrogen/progestin replacement study follow-up (HERS II): Part 2. Non-cardiovascular outcomes during 6.8 years of hormone therapy. JAMA 2002;288:58-66.
Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-333.
"Estrogen Plus Progestin Study Stopped Due to Increased Breast Cancer Risk, Lack of Overall Benefit." National Heart, Lung and Blood Institute. http://www.nhlbi.nih.gov. Updated July 9, 2002; accessed July 9, 2002.
"Women's Health Initiative," National Heart, Lung and Blood Institute. http://www.nhlbi.nih.gov. Updated July 9, 2002; accessed July 9, 2002.
"The Women's Health Initiative New Facts About: Estrogen/Progestin Therapy." National Heart, Lung and Blood Institute.http://www.nhlbi.nih.gov. Updated July 9, 2002; accessed July 9, 2002.
"Use of Hormone Replacement Therapy Questioned For Some Women: A Preliminary Response from The North American Menopause Society." http://www.nams.org. Updated July 9, 2002; accessed July 9, 2002.
Lacey, James V., et al. "Menopausal Hormone Replacement Therapy and Risk of Ovarian Cancer." JAMA 2002. Vol. 288:334-341.368-369.
Droegemuller, William. "Endometriosis and Adenomyosis: Etiology, Pathology, Diagnosis and Management," in Comprehensive Gynecology, 4th Ed., Stenchever, Droegemuller, Herbst, Michell (2001), p. 531-564.
"About DES (diethylstilboestrol)" Endometriosis.org. http://www.endometriosis.org. Dated 1999. Accessed August 2001.
"Endometriosis Family Study Identifies High Risk of Cancer and Autoimmune Diseases." Endometriosis Association. http://www.endometriosis.org. Dated 1999. Accessed August 2001.
Guidelines on the Treatment of Endometriosis: Update. American College of Obstetricians and Gynecologists (ACOG). Practice Bulletin no. 11, Obstetrics and Gynecology, Dec. 1999.
Reproductive Conditions-Endometriosis. Veritas Medicine. http://www.veritasmedicine.com. Dated 2001. Accessed August 2001.
The Endometriosis Association. http://www.endometriosisassn.org. July 2005.
Endometriosis.org http://www.endometriosis.org. July 2005.
Endometriosis. Mayo Clinic. Available at: http://www.mayoclinic.com. Accessed October 2005.
Berkley KJ, Rapkin AJ, Papka RE. The pains of endometriosis. Science. 2005 Jun 10;308(5728):1587-9.
| |
|
View References for this Health Topic
|
Create Date: 2/1/02
Date Last Updated: 12/14/05
Review Date: 11/30/05
|
|